Login / Signup

Impact of a clinical pharmacist on optimising the quality use of medicines according to the acute coronary syndrome (ACS) secondary prevention guidelines and medication adherence following discharge in patients with ACS in Sri Lanka: a prospective non-randomised controlled trial study protocol.

Nanayakkara Muhandiramalaya Yasakalum BagyawanthaIan D CoombesIndika GawarammanaMohamed Fahim
Published in: BMJ open (2023)
SLCTR/2019/039.
Keyphrases
  • acute coronary syndrome
  • study protocol
  • randomized controlled trial
  • percutaneous coronary intervention
  • antiplatelet therapy
  • clinical trial
  • open label
  • clinical practice
  • double blind